71 filings
8-K
VTRO
Vitro Biopharma, Inc.
17 Apr 24
Entry into a Material Definitive Agreement
5:27pm
8-K
VTRO
Vitro Biopharma, Inc.
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
8-K
VTRO
Vitro Biopharma, Inc.
12 Jan 24
Entry into a Material Definitive Agreement
6:02pm
8-K
VTRO
Vitro Biopharma, Inc.
22 Nov 23
Entry into a Material Definitive Agreement
1:55pm
8-K
VTRO
Vitro Biopharma, Inc.
19 Jul 23
Entry into a Material Definitive Agreement
4:11pm
8-K
naopx5b3qoaqrc8ih
7 Jul 23
Material Modifications to Rights of Security Holders
4:17pm
8-K
26ittq bntd5
16 Jun 23
Entry into a Material Definitive Agreement
4:15pm
8-K
hiftv
8 Jun 23
Entry into a Material Definitive Agreement
4:51pm
8-K/A
gml7n6x35g
12 May 23
Entry into a Material Definitive Agreement
4:13pm
8-K/A
uwder
12 May 23
Entry into a Material Definitive Agreement
4:10pm
8-K
ytjnwdv xo
20 Apr 23
Entry into a Material Definitive Agreement
5:14pm
8-K
haahnve1fn5ez2d5pal1
5 Apr 23
Entry into a Material Definitive Agreement
4:02pm
8-K
882s3u 2yjz
21 Mar 23
Entry into a Material Definitive Agreement
5:12pm
8-K
wpm6i2m0
17 Jan 23
Entry into a Material Definitive Agreement
4:05pm
8-K
thrg3e
16 Dec 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:05pm
8-K
096vaqt7ln0 u1rjzhx
28 Nov 22
Entry into a Material Definitive Agreement
4:48pm
8-K
j2oxzjn klrmmb
5 Oct 20
Vitro Biopharma 3rd Quarter ended July 31st 2020 Financial Results of Operations
5:20pm
8-K
rc0naao5d
5 Oct 20
Other Events
1:47pm
8-K
4iqlxhpdzg5vj
9 Jul 20
Vitro Biopharma 2nd Quarter ended April 30th 2020 Financial Results of Operations
12:23pm
8-K
iwhdo67lh1f5 ox4mve
4 Jun 20
Vitro Biopharma Signs MOU with GIOSTAR for COVID-19 IND Using AlloRx Stem Cells
2:41pm